Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin
Open Access
- 1 May 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 28 (2)
Abstract
Total hip arthroplasty (THA) is associated with a significant risk of venous thromboembolism (VTE). Different thromboprophylaxis strategies have been used to prevent VTE. The primary aim of this study was to report the incidence of VTE and compare the efficacy and safety of rivaroxaban to enoxaparin. The secondary outcome was to report the incidence of silent deep venous thrombosis (DVT) using computed tomography venography. One hundred sixty patients who underwent THA were enrolled in a prospective study. Patients were randomized into two groups as follows: those who received rivaroxaban 10 mg oral daily (group RXE) and those who received enoxaparin 40 IU/day subcutaneously for 14 days (group ENO). Both groups were matched for age, sex, comorbidities, special habits and preoperative laboratory investigations. The overall incidence of DVT was 5% (n = 8), which included four patients clinically diagnosed as having DVT and four with silent DVT. All the DVT cases occurred in veins below the knee and in the group RXE; none of the cases occurred in group ENO (p = 0.04). The incidence of DVT was significantly higher in patients with high body mass indexes (p < 0.001), older age (p = 0.024) and medical comorbidities (p = 0.14). No mortality, pulmonary embolism, stroke, wound infection or major bleeding occurred in either group. Among the patients who underwent hip arthroplasty, rivaroxaban prophylaxis was found to be associated with lower efficacy and similar safety outcomes as compared with enoxaparin anticoagulants.Keywords
This publication has 30 references indexed in Scilit:
- Apixaban and Rivaroxaban Decrease Deep Venous Thrombosis But Not Other Complications After Total Hip and Total Knee ArthroplastyThe Journal of Arthroplasty, 2013
- Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healingEuropean Journal of Orthopaedic Surgery & Traumatology, 2012
- Prevention of VTE in Orthopedic Surgery PatientsChest, 2012
- Venous Thromboembolism and Its Prophylaxis in Elective Total Hip Arthroplasty: An International PerspectiveHIP International, 2012
- Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementThe Journal of Bone and Joint Surgery. British volume, 2009
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip ArthroplastyNew England Journal of Medicine, 2008
- Prevention of Venous ThromboembolismChest, 2008
- Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysisClinical Radiology, 2008
- A profile of lower-limb deep-vein thrombosis: the hidden menace of below-knee DVTClinical Radiology, 2007
- Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patientsInternational Orthopaedics, 2007